<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39385106</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Correlation of COVID-19 vaccination and RT-PCR ct value among cases in Addis Ababa, Ethiopia: implication for future preparedness.</ArticleTitle><Pagination><StartPage>1127</StartPage><MedlinePgn>1127</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1127</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-10061-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The COVID-19 disease requires accurate diagnosis to effectively manage infection rates and disease progression. The study aims to assess the relationship between vaccination status and RT-PCR cycle threshold (Ct) values by comparing clinical, RDT and RT-PCR results.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 453 suspected COVID-19 cases were included in this study. Nasopharyngeal swabs were collected for both RDT and RT-PCR testing, with RDTs conducted on-site and RT-PCR at the Ethiopian Public Health Institute (EPHI) genomics laboratory. Detailed clinical, RDT, and RT-PCR results were analyzed. Data analysis included descriptive statistics, cross-tabulation, and Chi-Square tests to investigate the connections between diagnostic outcomes and vaccination status, with a focusing on Ct values.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">RDT results showed 34.0% negative and 65.8% positive, while RT-PCR results indicated 35.8% negative and 64.2% positive cases. The discrepancies between RDT and RT-PCR results emphasize the importance of thorough testing. No significant association was found between vaccination status and viral load, as indicated by Ct values. Among RT-PCR positive cases, 49.8% had been vaccinated, suggesting challenges in interpreting results among vaccinated individuals. Further analysis revealed that vaccination (first or second dose) had minimal impact on Ct values, indicating limited influence of vaccination status on viral load dynamics in infected individuals.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study highlights the significant differences between RDT and RT-PCR outcomes, underscoring the need for a comprehensive testing approach. Additionally, the findings suggest that vaccination status does not significantly impact RT-PCR Ct values, complicating the interpretation of diagnostic results in vaccinated individuals, especially in breakthrough infections and potential false positives.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aga</LastName><ForeName>Abebe M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia. agagurmu@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulugeta</LastName><ForeName>Demise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebreegziabxier</LastName><ForeName>Atsbeha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ethiopian Public Health Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Jemal</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alemu</LastName><ForeName>Anberber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tesera</LastName><ForeName>Yewenshet</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulugeta</LastName><ForeName>Frehiwot</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ethiopian Public Health Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gidisa</LastName><ForeName>Bedasa</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulti</LastName><ForeName>Jaleta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ethiopian Public Health Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadesse</LastName><ForeName>Gemechu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ethiopian Public Health Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadesse Woldemariyam</LastName><ForeName>Fanos</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigussie</LastName><ForeName>Dereje</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Armauer Hansen Research Institute, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005002" MajorTopicYN="N" Type="Geographic">Ethiopia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical symptoms</Keyword><Keyword MajorTopicYN="N">Ct value</Keyword><Keyword MajorTopicYN="N">RDT</Keyword><Keyword MajorTopicYN="N">RT_PCR</Keyword><Keyword MajorTopicYN="N">Test result</Keyword></KeywordList><CoiStatement>We declare that there are no conflicts of interest relevant to this study. No financial or personal relationships with individuals or organizations that could inappropriately influence or bias the content of this comparative study on COVID-19 detection methods have been disclosed. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385106</ArticleId><ArticleId IdType="pmc">PMC11465663</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-10061-4</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-10061-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alhassan RK, Nketiah-Amponsah E, Afaya A, Salia SM, Abuosi AA, Nutor JJ. Global health security index not a proven surrogate for health systems capacity to respond to pandemics: the case of COVID-19. J Infect Public Health. 2023;16(2):196–205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769026</ArticleId><ArticleId IdType="pubmed">36584636</ArticleId></ArticleIdList></Reference><Reference><Citation>Altawalah H, Alfouzan W, Al-Fadalah T, Ezzikouri S. Diagnostic performance of automated SARS-CoV-2 antigen assay in nasal swab during COVID-19 vaccination campaign. Diagnostics. 2021;11(11): 2110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621910</ArticleId><ArticleId IdType="pubmed">34829457</ArticleId></ArticleIdList></Reference><Reference><Citation>Aruleba RT, Adekiya TA, Ayawei N, Obaido G, Aruleba K, Mienye ID, Ogbuokiri B. COVID-19 diagnosis: a review of rapid antigen, RT-PCR and artificial intelligence methods. Bioengineering. 2022;9(4): 153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9024895</ArticleId><ArticleId IdType="pubmed">35447713</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC &amp;, Team R. Sars-cov-2 b. 1.1. 529 (omicron) variant—United States, December 1–8, 2021. Morb Mortal Wkly Rep. 2021;70(50):1731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8675659</ArticleId><ArticleId IdType="pubmed">34914670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong KC, Tay CJ, Khan MS, Hassan MA. COVID-19 testing and vaccination in Ethiopia: challenges and recommendations. Ethiop J Health Sci. 2023;33(1):45–53.</Citation></Reference><Reference><Citation>Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Balicer RD. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7944975</ArticleId><ArticleId IdType="pubmed">33626250</ArticleId></ArticleIdList></Reference><Reference><Citation>EPHI. 2021. https://ephi.gov.et/wp-content/uploads/2021/02/EPHI_PHEOC_COVID-19_Weekly_Bulletin_53_English_05072021.pdf.</Citation></Reference><Reference><Citation>Filchakova O, Dossym D, Ilyas A, Kuanysheva T, Abdizhamil A, Bukasov R. Review of COVID-19 testing and diagnostic methods. Talanta. 2022;244: 123409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970625</ArticleId><ArticleId IdType="pubmed">35390680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gize A, Kassa M, Ali S, Tadesse Y, Fantahun B, Habtu Y, Yesuf A. Epidemiological, clinical and laboratory profile of patients presenting with severe acute respiratory syndrome (SARS-CoV-2) in Ethiopia. PLoS ONE. 2023;18(12): e0295177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10691732</ArticleId><ArticleId IdType="pubmed">38039278</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Zhong NS. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Humer E, Keil T, Stupp C, Schlee W, Wildner M, Heuschmann P, Pryss R. Associations of country-specific and sociodemographic factors with self-reported covid-19–related symptoms: multivariable analysis of data from the coronacheck mobile health platform. JMIR Public Health Surveillance. 2023;9(1):e40958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9901499</ArticleId><ArticleId IdType="pubmed">36515987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrom D, Elston L, Washington J, Prettyjohns M, Cann K, Myles S, Groves P. Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review. BMJ evidence-based Med. 2022;27(1):33–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitara DL, Ikoona EN. Proposed strategies for easing COVID-19 lockdown measures in Africa. Pan Afr Med J. 2020;36(1):179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467889</ArticleId><ArticleId IdType="pubmed">32952823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliegr T, Jarkovský J, Jiřincová H, Kuchař J, Karel T, Chudán D, Tachezy R. Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022. Eurosurveillance. 2023;28(38):2200938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10515498</ArticleId><ArticleId IdType="pubmed">37733239</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine-Tiefenbrun M, Yelin I, Alapi H, Katz R, Herzel E, Kuint J, Kishony R. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nat Med. 2021;27(12):2108–10.</Citation><ArticleIdList><ArticleId IdType="pubmed">34728830</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, Weng C. A retrospective analysis of COVID-19 mRNA vaccine breakthrough infections–risk factors and vaccine effectiveness. Medrxiv. 2021.</Citation></Reference><Reference><Citation>Madhi SA, Nel J. Epidemiology of severe COVID-19 from South Africa. Lancet HIV. 2021;8(9):e524-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336967</ArticleId><ArticleId IdType="pubmed">34363788</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, Ganesh S, El-Sayed Moustafa JS, Visconti A, Spector TD. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. 2020. MedRxiv, 2020–04.</Citation></Reference><Reference><Citation>Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 test sensitivity—a strategy for containment. N Engl J Med. 2020;383(22): e120.</Citation><ArticleIdList><ArticleId IdType="pubmed">32997903</ArticleId></ArticleIdList></Reference><Reference><Citation>Olalekan A, Iwalokun B, Akinloye OM, Popoola O, Samuel TA, Akinloye O. COVID-19 rapid diagnostic test could contain transmission in low-and middle-income countries. Afr J Lab Med. 2020;9(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567180</ArticleId><ArticleId IdType="pubmed">33102170</ArticleId></ArticleIdList></Reference><Reference><Citation>Onuoha FC, Mbaegbu CC. Africa, virus and vulnerability: COVID-19 pandemic in Africa. Global Security in Times of Covid-19: Brave New World? Cham: Springer International Publishing; 2021. pp. 91–126.</Citation></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis. 2020;99:328–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263236</ArticleId><ArticleId IdType="pubmed">32497809</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y, Zeng T, Wang H, Xu M, Chen J, Hu N, Liu Y. Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019. Int J Nurs Sci. 2020;7(2):153–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129371</ArticleId><ArticleId IdType="pubmed">32292635</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner R, Collins JK, COVID-19 Forecasting Team, Murray CJ. (2023). Forecasting the trajectory of the COVID-19 pandemic into 2023 under plausible variant and intervention scenarios: a global modelling study. medRxiv, 2023-03.</Citation></Reference><Reference><Citation>Scohy A, Anantharajah A, Bodéus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129: 104455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240272</ArticleId><ArticleId IdType="pubmed">32485618</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagam A, Hakki S, Dunning J, Madon KJ, Crone MA, Koycheva A, Lackenby A. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. lancet Infect Dis. 2022;22(2):183–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554486</ArticleId><ArticleId IdType="pubmed">34756186</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni A, Herbert C, Filippaios A, Broach J, Colubri A, Fahey N, McManus D. Comparison of rapid antigen tests’ performance between Delta and Omicron variants of SARS-CoV-2: a secondary analysis from a serial home self-testing study. Ann Intern Med. 2022;175(12):1685–92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9578286</ArticleId><ArticleId IdType="pubmed">36215709</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf, T., Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Leeflang, M. M.,… Cochrane COVID-19 Diagnostic Test Accuracy Group. (2022). Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database of Systematic Reviews, (5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9121352</ArticleId><ArticleId IdType="pubmed">35593186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenhäuser I, Knies K, Pscheidl T, Eisenmann M, Flemming S, Petri N, Krone M. SARS-CoV-2 Antigen Rapid Detection Tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination. medRxiv. 2024;2024-04.</Citation></Reference><Reference><Citation>Watare SH, Alemu MA, Tayachew A, Yohannes N, Gizachew L, Kebede A, et al. An investigation of a hundred COVID-19 cases and close contacts in Ethiopia, May to June, 2020: a prospective case-ascertained study. PLoS One. 2022;17(10):e0275596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9565438</ArticleId><ArticleId IdType="pubmed">36240226</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHOa) (2020). WHO Director-General's opening remarks at the media briefing on COVID-19–11 March 2020.</Citation></Reference><Reference><Citation>World Health Organization (WHOb). Laboratory testing strategy recommendations for COVID-19: interim guidance. 2020. 21 March 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>